APA (7th ed.) Citation

Schilling, B., Hassel, J. C., & Utikal, J. (2014). Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma. Annals of oncology, 25(3), . https://doi.org/10.1093/annonc/mdt587

Chicago Style (17th ed.) Citation

Schilling, Bastian, Jessica C. Hassel, and Jochen Utikal. "Differential Influence of Vemurafenib and Dabrafenib on Patients' Lymphocytes Despite Similar Clinical Efficacy in Melanoma." Annals of Oncology 25, no. 3 (2014). https://doi.org/10.1093/annonc/mdt587.

MLA (9th ed.) Citation

Schilling, Bastian, et al. "Differential Influence of Vemurafenib and Dabrafenib on Patients' Lymphocytes Despite Similar Clinical Efficacy in Melanoma." Annals of Oncology, vol. 25, no. 3, 2014, https://doi.org/10.1093/annonc/mdt587.